Company Filing History:
6 out of 126 
6 out of 11 
1 out of 1,997 
Years Active: 1997-2006
Title: The Innovative Contributions of Laurence A. Borden
Introduction
Laurence A. Borden is a notable inventor based in Hackensack, NJ, with a remarkable portfolio of 13 patents. His work primarily focuses on advancements in pharmaceuticals and neurological treatments, showcasing his commitment to improving healthcare through innovation.
Latest Patents
Among his latest patents, Borden has developed a pharmaceutical for the treatment of neurological and neuropsychiatric disorders. This invention comprises a compound that offers potential therapeutic benefits for individuals suffering from these conditions. Additionally, he has worked on technologies related to peripheral nervous system specific sodium channels. This includes cloning, expression, and the development of viral delivery vectors that contain nucleic acids coding for peripheral nervous system specific sodium channel peptides. His work in this area aims to facilitate the isolation, crystallization, and molecular modeling of therapeutic agents that can modulate sodium channel activity.
Career Highlights
Borden has had a significant impact in the field of neuroscience through his roles in various companies. He has worked with Synaptic Pharmaceutical Corporation and Allelix Neuroscience Inc., where he contributed to groundbreaking research and development in neurological therapies.
Collaborations
Throughout his career, Borden has collaborated with esteemed colleagues, including Kelli E. Smith and Richard L. Weinshank. These partnerships have further enhanced his contributions to the field of neuroscience and pharmaceutical innovation.
Conclusion
Laurence A. Borden's innovative work in pharmaceuticals and neuroscience exemplifies the vital role of inventors in advancing medical science. His patents and collaborations reflect a dedication to improving treatments for neurological disorders, making a significant impact in the healthcare industry.